ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.267,66
0,45%
S&P 500
5.464,62
0,00%
Dow Jones
39.150,33
0,00%
Euro vs US Dollar
1,07283
0,38%
Bitcoin
61.201,31
-3,10%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. PureTech Health PLC (PRTC)

  7. PureTech Health PLC (PRTC) News

PRTC PureTech Health PLC

28,3901
0,00 (0,00%)
Vor Marktöffnung
Zuletzt aktualisiert: 14:20:18
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
PureTech Health PLC PRTC NASDAQ Depository Receipt
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,00 0,00% 28,3901 14:20:18
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
28,3901
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
24.6.202408:00BWPureTech Health: Results of the Tender Offer
20.6.202408:00BWPureTech Announces Change of Board Role
18.6.202413:05BWPureTech Founded Entity Seaport Therapeutics Appoints..
13.6.202422:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13.6.202419:15BWPureTech Health: Results of Annual General Meeting
06.6.202422:39EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
06.6.202422:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06.6.202418:38BWPureTech Health: Result of General Meeting
04.6.202422:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04.6.202413:01EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
30.5.202414:05EDGAR2Form SC 13D/A - General statement of acquisition of..
29.5.202422:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29.5.202414:09BWPureTech Founded Entity Akili Interactive and Virtual..
23.5.202413:00BWPureTech to Present at the Jefferies Global Healthcare..
21.5.202413:05BWPureTech Founded Entity Vedanta Biosciences Enrolls First..
20.5.202422:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20.5.202413:03EDGAR2Form SC TO-I - Tender offer statement by Issuer
20.5.202408:00BWPureTech Health: Launch of Proposed $100 Million Tender..
09.5.202413:05BWPureTech Founded Entity Seaport Therapeutics Presents Data..
07.5.202413:05BWPureTech Founded Entity Seaport Therapeutics Adds Industry..
25.4.202411:22BWPureTech Announces Annual Results for Year Ended December..
18.4.202408:00BWPureTech Health: Notice of Results
16.4.202413:00BWPureTech Announces Completion of Enrollment in Phase 2b..
11.4.202413:00BWPureTech Receives FDA Fast Track Designation for LYT-200 in..
09.4.202408:00BWPureTech Launches Seaport Therapeutics with $100 Million..
19.3.202408:00BWPureTech Proposes $100 Million Capital Return
18.3.202414:52BWBristol Myers Squibb Completes Acquisition of PureTech's..
13.3.202412:00BWPureTech Receives Orphan Drug Designation for LYT-200 in..
27.2.202413:00BWPureTech to Present at Two Upcoming Investor Conferences
27.2.202408:00BWPureTech Founded Entity Akili Announces Positive Results..
04.1.202422:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03.1.202413:00BWPureTech to Present at 42nd Annual J.P. Morgan Healthcare..
22.12.202315:13BWPureTech Founded Entity Karuna Therapeutics to be Acquired..
20.12.202308:00BWPureTech Year End Update and Outlook for 2024
07.12.202312:00BWPureTech Presents Data from Phase 1 Trial of LYT-200..
29.11.202316:17BWPureTech Founded Entity Karuna Therapeutics Announces U.S...
17.11.202308:00BWPureTech Founded Entity Karuna Therapeutics Announces..
14.11.202308:00BWPureTech's LYT-300 (Oral Allopregnanolone) Achieved Primary..
02.11.202321:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17.10.202308:00BWPureTech to Present at Two Upcoming Investor Conferences
11.10.202313:00BWPureTech Presents Data from LYT-100 (Deupirfenidone) Trial..
04.10.202313:05BWPureTech Founded Entity Vedanta Biosciences Announces First..
28.9.202313:38BWKarXT, invented at PureTech, submitted for FDA Approval in..
27.9.202308:05BWPureTech Announces the Appointment of Robert Lyne as Chief..
06.9.202322:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29.8.202312:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29.8.202308:00BWPureTech Health plc – Half-Year Report
22.8.202308:00BWPureTech Health: Notice of Half-Yearly Results
02.8.202322:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01.8.202313:00BWPureTech Awarded up to $11.4 Million from U.S. Department of..

Kürzlich von Ihnen besucht

NASDAQ
PRTC
PureTech Health
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten